annual CFF:
$381.23M+$294.71M(+340.66%)Summary
- As of today (August 30, 2025), SMMT annual cash flow from financing activities is $381.23 million, with the most recent change of +$294.71 million (+340.66%) on December 31, 2024.
- During the last 3 years, SMMT annual CFF has risen by +$303.31 million (+389.28%).
- SMMT annual CFF is now -38.54% below its all-time high of $620.24 million, reached on December 31, 2022.
Performance
SMMT Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$2.52M-$5.16M(-67.18%)Summary
- As of today (August 30, 2025), SMMT quarterly cash flow from financing activities is $2.52 million, with the most recent change of -$5.16 million (-67.18%) on June 30, 2025.
- Over the past year, SMMT quarterly CFF has dropped by -$197.21 million (-98.74%).
- SMMT quarterly CFF is now -99.49% below its all-time high of $497.17 million, reached on December 31, 2022.
Performance
SMMT quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$192.34M-$197.21M(-50.63%)Summary
- As of today (August 30, 2025), SMMT TTM cash flow from financing activities is $192.34 million, with the most recent change of -$197.21 million (-50.63%) on June 30, 2025.
- Over the past year, SMMT TTM CFF has dropped by -$12.98 million (-6.32%).
- SMMT TTM CFF is now -70.29% below its all-time high of $647.48 million, reached on June 30, 2023.
Performance
SMMT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
SMMT Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +340.7% | -98.7% | -6.3% |
| 3 y3 years | +389.3% | +409.5% | +694.4% |
| 5 y5 years | +692.6% | +4065.1% | +10000.0% |
SMMT Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -38.5% | +389.3% | -99.5% | +108.3% | -70.3% | +2763.9% |
| 5 y | 5-year | -38.5% | +692.6% | -99.5% | +108.3% | -70.3% | >+9999.0% |
| alltime | all time | -38.5% | >+9999.0% | -99.5% | +108.3% | -70.3% | >+9999.0% |
SMMT Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $2.52M(-67.2%) | $192.34M(-50.6%) |
| Mar 2025 | - | $7.68M(-125.4%) | $389.54M(+1.9%) |
| Dec 2024 | $381.23M(+340.7%) | -$30.27M(-114.2%) | $382.35M(-8.3%) |
| Sep 2024 | - | $212.41M(+6.3%) | $417.13M(+103.2%) |
| Jun 2024 | - | $199.73M(>+9900.0%) | $205.31M(+2957.1%) |
| Mar 2024 | - | $485.00K(-89.3%) | $6.72M(-92.2%) |
| Dec 2023 | $86.51M(-86.1%) | $4.51M(+671.3%) | $86.34M(-85.1%) |
| Sep 2023 | - | $585.20K(-48.3%) | $579.00M(-10.6%) |
| Jun 2023 | - | $1.13M(-98.6%) | $647.48M(+0.3%) |
| Mar 2023 | - | $80.11M(-83.9%) | $645.54M(+9.3%) |
| Dec 2022 | $620.24M(+696.0%) | $497.17M(+619.8%) | $590.61M(+533.1%) |
| Sep 2022 | - | $69.07M(-8584.2%) | $93.29M(+285.3%) |
| Jun 2022 | - | -$814.10K(-103.2%) | $24.21M(-47.0%) |
| Mar 2022 | - | $25.19M(<-9900.0%) | $45.64M(-40.2%) |
| Dec 2021 | $77.92M(+54.1%) | -$150.30K(+1195.7%) | $76.35M(-40.6%) |
| Sep 2021 | - | -$11.60K(-100.1%) | $128.55M(-0.0%) |
| Jun 2021 | - | $20.62M(-63.1%) | $128.57M(+19.0%) |
| Mar 2021 | - | $55.90M(+7.4%) | $108.01M(+107.5%) |
| Dec 2020 | $50.55M(+5.1%) | - | - |
| Dec 2020 | - | $52.05M(>+9900.0%) | $52.05M(>+9900.0%) |
| Sep 2020 | - | $100.00(-99.8%) | $3100.00(+3.3%) |
| Jun 2020 | - | $60.50K(-205.2%) | $3000.00(-105.2%) |
| Mar 2020 | - | -$57.50K(-100.2%) | -$57.50K(-100.1%) |
| Dec 2019 | $48.10M(+166.1%) | - | - |
| Jan 2019 | - | $24.70M(-4505.1%) | $42.88M(+130.1%) |
| Oct 2018 | - | -$560.80K(-48.4%) | $18.64M(-50.2%) |
| Jul 2018 | - | -$1.09M(-105.5%) | $37.44M(-2.9%) |
| Apr 2018 | - | $19.82M(+4220.0%) | $38.55M(+105.7%) |
| Jan 2018 | $18.08M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2018 | - | $458.90K(-97.5%) | $18.74M(+2.5%) |
| Oct 2017 | - | $18.24M(>+9900.0%) | $18.28M(+4823.2%) |
| Jul 2017 | - | $27.70K(+71.0%) | $371.40K(-1.3%) |
| Apr 2017 | - | $16.20K(+1250.0%) | $376.30K(-26.6%) |
| Jan 2017 | $550.50K(-98.4%) | - | - |
| Jan 2017 | - | $1200.00(-99.6%) | $512.90K(-170.4%) |
| Oct 2016 | - | $326.30K(+900.9%) | -$728.60K(-44.6%) |
| Jul 2016 | - | $32.60K(-78.7%) | -$1.32M(+637.3%) |
| Apr 2016 | - | $152.80K(-112.3%) | -$178.50K(-100.5%) |
| Jan 2016 | $33.68M(+0.3%) | - | - |
| Jan 2016 | - | -$1.24M(+375.0%) | $32.87M(+3.6%) |
| Oct 2015 | - | -$261.10K(-122.3%) | $31.73M(+6.3%) |
| Jul 2015 | - | $1.17M(-96.5%) | $29.85M(+3.6%) |
| Apr 2015 | - | $33.20M(-1492.5%) | $28.82M(-5.5%) |
| Jan 2015 | $33.59M(+381.0%) | - | - |
| Jan 2015 | - | -$2.38M(+11.5%) | $30.48M(-7.3%) |
| Oct 2014 | - | -$2.14M(-1653.3%) | $32.86M(-6.1%) |
| Jul 2014 | - | $137.70K(-99.6%) | $35.00M(+0.4%) |
| Apr 2014 | - | $34.86M | $34.86M |
| Jan 2014 | $6.98M(-3.5%) | - | - |
| Jan 2013 | $7.23M(+232.3%) | - | - |
| Jan 2012 | $2.18M(+8714.2%) | - | - |
| Jan 2011 | $24.70K(-99.7%) | - | - |
| Jan 2010 | $8.02M(+22.0%) | - | - |
| Jan 2009 | $6.57M(+389.3%) | - | - |
| Jan 2008 | $1.34M(-92.7%) | - | - |
| Jan 2007 | $18.34M(+1240.5%) | - | - |
| Jan 2006 | $1.37M(-94.7%) | - | - |
| Jan 2005 | $25.81M(>+9900.0%) | - | - |
| Jan 2004 | $249.60K | - | - |
FAQ
- What is Summit Therapeutics Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. annual CFF year-on-year change?
- What is Summit Therapeutics Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. quarterly CFF year-on-year change?
- What is Summit Therapeutics Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. TTM CFF year-on-year change?
What is Summit Therapeutics Inc. annual cash flow from financing activities?
The current annual CFF of SMMT is $381.23M
What is the all time high annual CFF for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high annual cash flow from financing activities is $620.24M
What is Summit Therapeutics Inc. annual CFF year-on-year change?
Over the past year, SMMT annual cash flow from financing activities has changed by +$294.71M (+340.66%)
What is Summit Therapeutics Inc. quarterly cash flow from financing activities?
The current quarterly CFF of SMMT is $2.52M
What is the all time high quarterly CFF for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high quarterly cash flow from financing activities is $497.17M
What is Summit Therapeutics Inc. quarterly CFF year-on-year change?
Over the past year, SMMT quarterly cash flow from financing activities has changed by -$197.21M (-98.74%)
What is Summit Therapeutics Inc. TTM cash flow from financing activities?
The current TTM CFF of SMMT is $192.34M
What is the all time high TTM CFF for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high TTM cash flow from financing activities is $647.48M
What is Summit Therapeutics Inc. TTM CFF year-on-year change?
Over the past year, SMMT TTM cash flow from financing activities has changed by -$12.98M (-6.32%)